Chiao‐En Wu

机构：Chang Gung University of Science and Technology, Chang Gung University, Chang Gung Memorial Hospital, University of Florida, Taipei Tzu Chi Hospital, Linkou Chang Gung Memorial Hospital, Florida College · ORCID：0000-0002-1900-2984

发表论文 25 篇 · 总被引 193 次 · h-index 10

代表论文

• Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan (2023 · Targeted Oncology · 被引 27)
• Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan (2022 · Thoracic Cancer · 被引 21)
• Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI (2022 · Cancers · 被引 21)
• Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study (2021 · BMC Cancer · 被引 20)
• Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms. (2012 · PubMed · 被引 18)
• Real-world Afatinib Outcomes in Advanced Non–small Cell Lung Cancer Harboring EGFR Mutations (2022 · Anticancer Research · 被引 17)